| Literature DB >> 29268748 |
Mona Badawy1,2, Birgitte Espehaug3, Anne Marie Fenstad4, Kari Indrekvam5,6, Håvard Dale6, Leif I Havelin4,6, Ove Furnes4,6.
Abstract
BACKGROUND: The aim of this study was to assess which patient and procedure factors affected both the risk of infection as well as procedure duration. Additionally, to assess if procedure duration affected the revision risk due to deep infection in total knee arthroplasty (TKA) patients and in a subgroup of low-risk patients.Entities:
Keywords: Arthroplasty; Infection; Knee; Osteoarthritis; Procedure duration; Revision; Risk factors
Mesh:
Year: 2017 PMID: 29268748 PMCID: PMC5740908 DOI: 10.1186/s12891-017-1915-4
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Flow chart with inclusion and exclusion criteria for total knee arthroplasties (TKA) reported to the Norwegian Arthroplasty Register from 2005 to 2015. Knees treated with uncemented, hybrid, cemented without antibiotics, unicompartmental, PS (posterior stabilized), CCK (constrained condylar knee), hinged, stemmed implants and TKA with patellar component were excluded for homogeneity reasons. Only TKAs with known operation time were included
Cox regression analysis. Risk of revision due to deep infection for all TKA patients in four different procedure duration groups
| Cox regressionc | ||||||||
|---|---|---|---|---|---|---|---|---|
| Unadjusted | Adjusted | |||||||
| Procedure duration | No of TKA | No of revisionsa | K-M 1y %b | K-M 4y %b | HR (95% CI) |
| HR (95% CI) |
|
| 0.01d | 0.03d | |||||||
| <75 | 5680 | 48 | 0.60 | 0.89 | 1 | 1 | ||
| 75-89 | 6238 | 54 | 0.58 | 0.85 | 1.1 (0.7 - 1.5) | 1.0 | 1.0 (0.7 - 1.4) | 0.9 |
| 90-109 | 8659 | 91 | 0.63 | 1.01 | 1.2 (0.9 – 1.7) | 0.3 | 1.1 (0.8 – 1.6) | 0.5 |
| ≥110 | 7685 | 118 | 0.91 | 1.38 | 1.8 (1.3 – 2.5) | 0.001 | 1.5 (1.0 – 2.1) | 0.03 |
aNumber of revisions due to deep infection (n = 311)
bKaplan-Meier estimated proportion of revisions due to deep infection at 1 and 4 years follow-up
cUnadjusted and adjusted Hazard ratios (HR) estimated with the Cox proportional hazards model (adjusted for sex, age, diagnosis, ASA classification and perioperative complications
dOverall test for group differences
Cox regression analysis. Risk of revision due to deep infection for the low-risk patienta in four different procedure duration groups
| Cox regressiond | ||||||||
|---|---|---|---|---|---|---|---|---|
| Unadjusted | Adjusted | |||||||
| Procedure duration | No of TKA | No of revisionsb | K-M 1y %c | K-M 4y %c | HR (95% CI) |
| HR (95% CI) |
|
| <75 | 3232 | 31 | 0.68 | 1.00 | 1 | 1 | ||
| 75-89 | 3718 | 30 | 0.57 | 0.84 | 0.8 (0.5 - 1.4) | 0.5 | 0.8 (0.5 - 1.3) | 0.4 |
| 90-109 | 5130 | 44 | 0.49 | 0.78 | 0.9 (0.6 – 1.4) | 0.6 | 0.8 (0.5 – 1.3) | 0.4 |
| ≥110 | 4177 | 52 | 0.72 | 1.10 | 1.2 (0.8 – 1.9) | 0.3 | 1.1 (0.7 – 1.7) | 0.6 |
aThe low-risk TKA patient: TKA patient with primary osteoarthritis, ASA 1 or 2, without any previous surgery to the knee and no registered perioperative complications (n = 16,257)
bNumber of revisions due to deep infection (n = 157)
cKaplan-Meier estimated proportion of revisions due to deep infection at 1 and 4 years follow-up
dUnadjusted and adjusted Hazard ratios (HR) estimated with the Cox proportional hazards model, adjusted for sex and age
Patient and procedure characteristics at primary TKA relative to the four procedure duration groups
| Procedure Duration Groups | |||||
|---|---|---|---|---|---|
| < 75 min | 75 – 89 | 90 – 109 | ≥110 |
| |
| Number of procedures | 5680 | 6238 | 8659 | 7685 | |
| Year of operation 2010-2014 ( | 60 | 58 | 57 | 52 | P < 0.001 |
| Male sex ( | 28 | 31 | 37 | 44 | P < 0.001 |
| Age group % | P < 0.001 | ||||
| <60 ( | 15 | 17 | 17 | 21 | |
| 60-69 ( | 33 | 34 | 34 | 36 | |
| 70-79 (n = 10,009) | 38 | 36 | 36 | 32 | |
| ≥80 ( | 14 | 13 | 13 | 11 | |
| Median age (years) (range) | 71 (31-96) | 70 (25-94) | 70 (23-101) | 68 (22-93) | |
| Median annual hospital volume | 118 | 113 | 95 | 86 | P < 0.001 |
| ASA % | P = 0.001 | ||||
| 1 ( | 16 | 14 | 14 | 16 | |
| 2 ( | 64 | 65 | 64 | 62 | |
| 3+ ( | 19 | 19 | 20 | 21 | |
| Osteoarthritis ( | 92 | 90 | 88 | 87 | P < 0.001 |
| Perioperative complications ( | 0.7 | 1.1 | 1.8 | 4.9 | P < 0.001 |
| Previous surgery for intraarticular fracture or fracture near the joint ( | 0.8 | 1.3 | 1.7 | 3.6 | P < 0.001 |
| Previous high tibial osteotomy ( | 1.9 | 2.5 | 2.8 | 4.9 | P < 0.001 |
| Computer navigated TKA ( | 2.5 | 5.6 | 9.0 | 18 | P < 0.001 |
| Systemic antibiotics ( | 100 | 100 | 100 | 100 |
|
| Prosthesis brand % |
| ||||
| LCS Complete ( | 26 | 31 | 31 | 34 | |
| Profix ( | 23 | 24 | 23 | 20 | |
| NexGen ( | 18 | 16 | 16 | 17 | |
| AGC ( | 15 | 7.3 | 6.1 | 5.1 | |
| Duracon ( | 5.7 | 6.8 | 6.8 | 9.2 | |
| Triathlon ( | 5.2 | 4.0 | 5.2 | 4.1 | |
| Vanguard ( | 1.5 | 1.7 | 3.7 | 3.0 | |
| PFC-Sigma ( | 1.3 | 2.6 | 3.0 | 2.7 | |
| LCS ( | 1.3 | 1.2 | 2.0 | 2.5 | |
| Other ( | 3.3 | 5.0 | 2.9 | 2.7 | |
Patient and procedure related risk factors for revision due to infection after primary TKA
| Variables | No | RR (95% CI) | RR (95% CI) |
| |
|---|---|---|---|---|---|
| Age | |||||
| 60-69 | 9717 | 1 | 1 | ||
| < 60 | 4989 | 0.9 (0.7-1.3) | 0.7 | 0.9 (0.7-1.3) | 0.6 |
| 70-79 | 10,009 | 0.8 (0.6-1.0) | 0.1 | 0.8 (0.6-1.1) | 0.1 |
| > 80 | 3547 | 0.7 (0.5-1.1) | 0.1 | 0.7 (0.5-1.1) | 0.1 |
| Sex | |||||
| men | 10,186 | 1 | 1 | ||
| women | 18,076 | 0.5 (0.4-0.6) | <0.001 | 0.5 (0.4-0.6) | <0.001 |
| Diagnosis | |||||
| OAa | 25,152 | 1 | 1 | ||
| Otherb | 3110 | 1.6 (1.2-2.1) | 0.004 | 1.4 (1.0-2.0) | 0.04 |
| ASA | |||||
| 1 | 4167 | 1 | 1 | ||
| 2 | 17,918 | 1.1 (0.8-1.5) | 0.7 | 1.2 (0.8-1.7) | 0.4 |
| 3+ | 5621 | 1.7 (1.2-2.5) | 0.005 | 1.8 (1.2-2.7) | 0.003 |
| Hospital volume | |||||
| 1-49 | 3953 | 1 | 1 | ||
| 50-99 | 10,615 | 1.1 (0.8-1.6) | 0.5 | 1.1(0.8-1.6) | 0.5 |
| 100-149 | 6379 | 1.2 (0.8-1.7) | 0.4 | 1.1 (0.7-1.7) | 0.6 |
| ≥ 150 | 7315 | 1.2 (0.8-1.7) | 0.4 | 1.1 (0.7-1.7) | 0.6 |
| Perioperative complications | |||||
| no | 27,068 | 1 | 1 | ||
| yes | 640 | 2.3 (1.4-3.9) | 0.002 | 2.1 (1.3-3.6) | 0.004 |
| Computer navigation | |||||
| no | 23,626 | 1 | 1 | ||
| yes | 2462 | 1.0 (0.7-1.5) | 1.0 | 1.0 (0.7-1.5) | 1.0 |
| Prior fracturec | |||||
| no | 27,711 | 1 | 1 | ||
| yes | 551 | 2.20(1.1-3.6) | 0.02 | 1.5 (0.8-2.7) | 0.2 |
| Prior osteotomyd | |||||
| no | 27,377 | 1 | 1 | ||
| yes | 885 | 0.9 (0.5-1.8) | 0.8 | 0.8 (0.4-1.5) | 0.5 |
| TKA implant brands | |||||
| LCS Complete | 8752 | 1 | 1 | ||
| AGC | 2233 | 0.8 (0.5-1.3) | 0.3 | 0.8 (0.5-1.3) | 0.3 |
| LCS | 516 | 1.1 (0.5-2.3) | 0.9 | 1.3 (0.6-2.9) | 0.5 |
| Duracon | 2043 | 1.6 (1.1-2.3) | 0.02 | 1.5 (0.8-2.7) | 0.2 |
| NexGen | 4717 | 1.2 (0.8-1.6) | 0.4 | 1.0 (0.7-1.4) | 1.0 |
| Profix | 6286 | 0.9 (0.6-1.2) | 0.4 | 0.9 (0.6-1.2) | 0.4 |
| PFC Sigma | 697 | 1.0 (0.4-2.3) | 1.0 | 0.9 (0.4-2.0) | 0.7 |
| Triathlon | 1317 | 1.0 (0.6-1.8) | 1.0 | 0.9 (0.5-1.5) | 0.6 |
| Vanguard TM | 741 | 0.3 (0.1-1.0) | 0.06 | 0.2 (0.1-0.8) | 0.03 |
| Otherse | 955 | 0.4 (0.1-1.0) | 0.05 | 0.4 (0.1-1.0) | 0.06 |
| Time Period | |||||
| 2005-2009 | 12,362 | 1 | 1 | ||
| 2010-2014 | 15,900 | 1.3 (1.0-1.6) | 0.03 | 1.3 (1.0-1.6) | 0.08 |
aOA = Osteoarthritis
bOther = other diagnosis than osteoarthritis, e.g. inflammatory diseases
cIntraarticular fracture or fracture in proximity to the joint with previous osteosynthesis
dPrevious knee osteotomy for knee malalignment
eImplant brands used in smaller numbers than 500 during the time period from 2005 to 2014
Fig. 2Cox regression survival curve for all included primary TKA with revision due to deep infection as endpoint for four different procedure duration groups. Adjusted for sex, age, diagnosis, ASA classification and perioperative complications
Fig. 3Cox regression survival curve for “low-risk” primary TKA patients with revision due to deep infection as endpoint for four different procedure duration groups with adjustment for age and sex. “Low-risk” TKA patient: patient with primary osteoarthritis, with ASA 1 or 2, without any previous surgery to the knee and no registered perioperative complications